Digital Health for Obesity Market to Register 21.4% CAGR During 2025–2034

Overview

The Global Digital Health for Obesity Market Size is expected to be worth around US$ 407.5 Billion by 2034, from US$ 58.6 Billion in 2024, growing at a CAGR of 21.4% during the forecast period from 2025 to 2034.

Rising obesity prevalence and the growing need for accessible, continuous weight-management support are strengthening the role of digital health technologies in obesity care. The World Health Organization (WHO) reported that more than 1 billion people worldwide were living with obesity in 2022, highlighting the scale of the global public-health challenge.

Digital health solutions can support obesity prevention and management through mobile health applications, telemedicine, connected devices, remote monitoring, digital coaching, and personalized health-management platforms. WHO has emphasized that digital technologies can improve healthcare delivery, strengthen access to services, and support evidence-based interventions for noncommunicable diseases.

The burden is also substantial in the United States. According to the CDC, 40.3% of U.S. adults aged 20 years and older had obesity during August 2021–August 2023, while 9.7% had severe obesity. The CDC’s 2024 state-level data further showed that every U.S. state and territory recorded an adult obesity prevalence of at least 25%, reinforcing the demand for scalable prevention and treatment approaches.

Regulatory developments are also supporting innovation. In March 2026, the FDA issued final guidance covering medical devices with indications associated with weight loss, including recommendations for clinical study design and benefit-risk assessment. As healthcare providers increasingly combine digital monitoring, behavioral support, clinical care, and evidence-based therapies, digital health platforms are positioned to become an important component of comprehensive obesity management.

Key Takeaways

• The global digital health for obesity market was valued at USD 58.6 billion in 2024 and is projected to reach USD 407.5 billion by 2034, expanding at a CAGR of 21.4% during the forecast period.
• In 2024, the services segment dominated the global digital health for obesity market, accounting for 38.4% of the overall revenue share.
• The patients segment represented the leading end-user category in 2024, capturing 34.8% of the global market revenue.
• North America held the dominant position in the global digital health for obesity market in 2024, accounting for more than 41.2% of the total revenue share.

Statistical Information

• 57% of U.S. individuals accessed their online medical records through an app in 2024, up from 38% in 2020, demonstrating growing consumer preference for mobile-based healthcare access.
• 69% of U.S. individuals managing a chronic condition accessed their online medical records in 2024, compared with the national rate of 65%, indicating strong digital engagement among people requiring ongoing care.
• 87% of individuals who were encouraged by their healthcare provider to use a patient portal accessed it in 2024, compared with only 57% among those who were not encouraged. This highlights the importance of provider-supported digital engagement.
• 59% of U.S. individuals had multiple online medical records or patient portals in 2024, while only 7% used a portal-organizing application, pointing to an opportunity for integrated digital-health platforms.
• 71.4% of U.S. physicians reported using telehealth weekly in 2024, compared with 25.1% in 2018, demonstrating the continued integration of virtual care into clinical practice.
• In a randomized digital-therapeutic trial, 74% of participants in the intervention group downloaded and completed the mobile application program, demonstrating substantial engagement with app-supported weight management.
• A randomized clinical trial of 437 participants found that adding telephone coaching to an online weight-loss program improved both weight-loss outcomes and engagement among participants showing an inadequate early response.
• A U.S. randomized clinical trial comparing an AI-powered lifestyle intervention using a mobile app and Bluetooth-enabled digital scale with a human-coach program evaluated whether AI-led care could deliver clinically meaningful weight-management outcomes, supporting the development of automated personalized obesity-management services.
• In March 2026, the FDA issued final guidance for weight-loss medical devices, providing recommendations on non-clinical testing, clinical-study design, and benefit-risk assessment. This creates clearer regulatory considerations for companies developing obesity-focused digital and connected-device solutions.

Market Segmentation Analysis

Component Analysis

Based on component, the global digital health for obesity market is segmented into services, hardware, and software. The services segment dominated the market in 2024, accounting for 38.4% of the total revenue share. Its leadership is supported by the growing demand for personalized and continuous obesity-management solutions, including virtual health coaching, nutritional counseling, behavioral support, and telemedicine consultations.

Unlike standalone technologies, services provide ongoing guidance and interaction, helping improve patient engagement and adherence. The increasing preference for holistic, patient-centered weight-management programs is further strengthening demand for these offerings. As digital obesity care continues to evolve, services are expected to remain a key component of market growth.

End Use Analysis

Based on end use, the global digital health for obesity market is segmented into patients and other end users. Patients dominated the market in 2024, capturing 34.8% of the total revenue share. This leadership reflects increasing consumer adoption of digital tools that support convenient and personalized weight management. Mobile health applications, wearable devices, remote monitoring platforms, and telemedicine services enable users to track progress, receive personalized guidance, and access healthcare support remotely.

The integration of artificial intelligence and machine learning is also improving personalization and user engagement. Growing emphasis on self-managed healthcare, combined with increasing accessibility of digital solutions, is expected to sustain patient demand and strengthen their leading position in the market.

Regional Analysis

North America dominated the global digital health for obesity market in 2024, accounting for more than 41.2% of the total market revenue. The region’s leading position is supported by advanced healthcare infrastructure, widespread adoption of digital health technologies, and increasing demand for accessible obesity-management solutions. The United States represents a major contributor to regional growth, driven by the growing use of telehealth services, mobile health applications, wearable devices, remote patient monitoring, and digital coaching platforms.

The presence of established healthcare technology companies and increasing integration of artificial intelligence into digital healthcare solutions are also supporting market development. In addition, growing awareness of obesity prevention and long-term weight management is encouraging patients and healthcare providers to adopt technology-enabled care. Strong healthcare investment and continued innovation are expected to reinforce North America’s leadership in the global digital health for obesity market during the forecast period.

Business Opportunities

The global digital health for obesity market presents significant business opportunities as healthcare providers, technology companies, and pharmaceutical organizations increasingly adopt technology-enabled approaches to weight management. One major opportunity lies in personalized digital obesity-management platforms that combine mobile applications, behavioral coaching, nutrition guidance, activity tracking, and remote monitoring. Integration of artificial intelligence can further improve personalization by delivering tailored recommendations based on individual health data.

Telehealth and virtual care services also offer strong opportunities by connecting patients with physicians, dietitians, and behavioral specialists without requiring frequent in-person visits. Companies can develop subscription-based platforms that provide continuous support and monitoring, creating recurring revenue streams.

Another opportunity exists in integrating wearable devices and connected health technologies with digital obesity platforms. Real-time tracking of physical activity, sleep, heart rate, and other health indicators can strengthen patient engagement and generate actionable insights.

Partnerships between digital health companies, healthcare providers, employers, insurers, and pharmaceutical firms can expand market reach. Businesses can also focus on secure data management, clinical integration, and evidence-based digital interventions to build trust and achieve long-term adoption.

Emerging Trends

• AI-powered personalization: AI is moving obesity care toward individualized recommendations based on weight, activity, diet, and behavioral data. A 2025 randomized trial evaluated an AI-led lifestyle program using a mobile app and Bluetooth scale against remote human coaching at two U.S. clinical sites.
• Hybrid digital and clinical care: Digital obesity management is increasingly shifting toward hybrid models rather than fully remote treatment. A 2026 trial randomized 100 adolescents to telehealth or face-to-face care, with telehealth including weekly remote consultations and a gamified step-monitoring application.
• Expansion into pediatric obesity: Children and adolescents are becoming an important target for digital obesity solutions. A 2025 evidence review identified 15 studies involving 911 participants, covering mobile apps, wearables, telehealth, text messaging, and active video gaming for younger populations.
• Immersive and gamified technologies: Gamification and virtual reality are emerging as tools for improving motivation, exercise, and behavioral change. A 2025 systematic review identified 23 VR studies, including 11 focused on obesity, with evidence examining exercise, cognitive-behavioral therapy, and weight-management outcomes.
• Greater focus on long-term engagement: Digital obesity products are increasingly being designed around sustained participation rather than short-term weight loss. A 2025 meta-analysis covering 261 primary studies and 62,407 participants found mobile interventions produced modest but significant weight reductions, while long-term sustainability remains an important development priority.

Use Cases

• Remote obesity consultations: Telehealth platforms can connect patients with multidisciplinary obesity specialists without requiring frequent clinic visits. Current programs combine remote consultations, digital monitoring, and lifestyle guidance, allowing providers to follow progress between appointments and expand access to structured weight-management services.
• Connected weight monitoring: Smart scales and wearable trackers can automatically capture weight and activity information for digital programs. In a randomized study of 400 adults, wireless monitoring combined with coaching produced greater six-month weight loss than the wireless system alone.
• Digital dietary monitoring: Smartphone applications can replace or supplement traditional food diaries by enabling regular dietary self-monitoring. A 2025 pilot randomized trial involving 60 adolescents aged 13–17 found app-based dietary monitoring produced improvements comparable to conventional food-record methods.
• Breath-based metabolic monitoring: New digital solutions are combining mobile applications with connected biosensing devices. A one-year study involving 155 adults used a breath-acetone device with an mHealth application and Bluetooth scales, demonstrating an emerging use case for real-time metabolic feedback during weight management.
• Digital coaching and adaptive interventions: Platforms can use patient-generated data to determine when additional support is needed. In a randomized study, participants receiving wireless monitoring plus coaching lost 4.8 kg over six months, compared with 2.8 kg using monitoring alone.

Recent Developments

• In April 2026, Noom Health reported that its SmartRx program was on track to reduce GLP-1 medication spending by nearly 80% for its first participating employer, projecting annual spending of about $1.3 million versus $6.2 million previously. The program began integration in January 2026 and covers 24,638 enrolled members.
• In April 2026, Noom completed its acquisition of Tailor Made Compounding, a licensed 503A pharmacy operating in 46 U.S. states. The acquisition strengthens Noom’s prescription infrastructure and expands its ability to combine pharmacy services with its digital behavior-change and weight-health platform.
• In January 2026, BioAge Labs completed an upsized $132.3 million follow-on public offering to advance its clinical development programs. The company had also expanded development of BGE-102, an oral therapy being investigated for obesity and related metabolic conditions.
• In January 2026, MOBE announced a partnership and strategic investment in Sidekick Health to strengthen personalized digital support for people managing multiple chronic conditions. The collaboration expands Sidekick’s platform for health plans and employers, including cardiometabolic and medication-support capabilities.
• In July 2025, WW International completed its strategic financial reorganization and relisted on Nasdaq, giving the company greater financial flexibility. It also appointed Dr. Kim Boyd as Chief Medical Officer and expanded its integrated weight-health model to combine medical, behavioral, nutritional, and community-based support.
• In April 2025, the European Investment Bank provided Sidekick Health with a €35 million venture-debt facility to accelerate R&D, expand its digital therapeutics portfolio, enhance AI capabilities, and strengthen data and platform infrastructure for scalable digital healthcare solutions.

Conclusion
The global digital health for obesity market is entering a strong growth phase, supported by rising demand for convenient, personalized, and continuous weight-management solutions. Services and patient-focused applications currently represent major areas of opportunity, while North America remains the leading regional market. Advances in artificial intelligence, telehealth, connected devices, digital coaching, and remote monitoring are expanding the range of obesity-care applications.

Recent investments, partnerships, acquisitions, and product developments further demonstrate increasing industry activity. As healthcare providers and patients increasingly adopt technology-enabled care, businesses that combine clinical support, personalized digital experiences, secure data management, and evidence-based interventions are well positioned to capture emerging opportunities across the global obesity-management ecosystem.